Executive Summary

Feb 2019
PROSPECTS
Category benefits from greater access to information and the resulting destigmatisation of skin conditions

Greater access to information online is making it easier for consumers to research symptoms, with this trend having been heavily supported by the widening ownership of smartphones. As a result, consumers who were previously embarrassed to discuss symptoms in public are now more comfortable asking for OTC dermatologicals such as haemorrhoid treatments, vaginal antifungals and antiparasitics/lice (head and body) treatments.

Growth set to be constrained over the forecast period by the challenging economic environment

Dermatologicals is expected to record a slightly weaker performance over the forecast period when compared to the review period with this projection based on a combination of factors. Consumers are under increasing financial pressure and are cutting back on non-essential items.

Prevalence of dermatophytosis drives demand for topical antifungals

Topical antifungals is by far the largest category of dermatologicals and it is expected to see a similar performance to the one recorded over the review period with well-known brands such as Lamisil helping to sustain growth. These products are used to treat dermatophytosis which is a common ailment in South Africa that affects the skin and nails and is one which consumers are keen to treat as soon as it arises as it can produce an unsightly rash as well as sore skin.

COMPETITIVE LANDSCAPE
International manufacturers lead dermatologicals thanks to strong and well-established brands

Four of the leading five players in dermatologicals in 2018 are international companies. However, the category remains highly fragmented, with no one player holding a double-digit value share.

Niche players hold a significant share of sales

In such a highly fragmented category, small players account for a significant share of overall value sales. These companies often do not have large marketing budgets but their success can in part be explained by the fact that doctors and pharmacists recommend their products, which are available in different channels.

Phenergan dominates topical allergy remedies/antihistamines

Sanofi-Aventis’ Phenergan benefits from being a well-known and trusted brand with it being widely recommended by pharmacists. With rising awareness and incidence of allergies this has helped the brand to grow with it seen as one of the most effective treatments.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in South Africa

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in South Africa with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in South Africa, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in South Africa market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in South Africa?
  • What are the major brands in South Africa?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in South Africa - Category analysis

HEADLINES

PROSPECTS

Category benefits from greater access to information and the resulting destigmatisation of skin conditions
Growth set to be constrained over the forecast period by the challenging economic environment
Prevalence of dermatophytosis drives demand for topical antifungals

COMPETITIVE LANDSCAPE

International manufacturers lead dermatologicals thanks to strong and well-established brands
Niche players hold a significant share of sales
Phenergan dominates topical allergy remedies/antihistamines

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Consumer Health in South Africa - Industry Overview

EXECUTIVE SUMMARY

Self-medication and challenging economic climate impact growth
Uncertainty persists surrounding amendments to the Complementary and Alternative Medicines (CAMs) Act
Adcock Ingram maintains its leading position while private label is on the rise
Chemists/pharmacies remains the leading distribution channel
Health and wellness and self-medication trends open up new opportunities for consumer health players

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

SOURCES

Summary 1 Research Sources